Dermatologists use advanced atopic dermatitis treatments but lack predictive biomarkers for precise therapy selection.
Patients with eye disease face worsening conditions after losing access to copay assistance for anti-VEGF drugs, study reveals.
Dermatologists propose ending routine blood tests for isotretinoin patients without risk factors to streamline acne treatment.